A recent study reveals that people who stop using new GLP-1 drugs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who end conventional diet and exercise programs.
Published data in a major health publication demonstrates that while overweight people frequently drop about a fifth of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"People using such medications should be cognizant of the potential of fast weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.
Such speed of regain means a reversion to starting weight in about 18 months.
Comparing Approaches
The analysis, which examined dozens of studies involving thousands of participants, compared the effects of these new drugs with older methods.
Scientists point out that individuals who lose weight through dieting usually experience a slower creep back—around 0.1 kg a month—once they finish.
Explaining the Quick Regain
Experts believe the way of the jabs is key to understanding the amplified regain.
These medications mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing the hormone levels far above than the body's typical production may cause the body to produce less of its own natural hormone, and may also lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication means hunger is uncontrolled, making excessive eating a significant risk."
A Lifelong Disease?
Medical guidelines recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts argue that, due to the likelihood of weight regain, the therapy might need to be life-long.
This view is supported by pharmaceutical companies, who note that the findings "highlight the chronic nature of obesity," similar to managing conditions like diabetes.
User Testimonies
Individuals who have discontinued the jabs report a sudden return of appetite.
"It felt as if a trigger flipping and you're instantly ravenous," said one woman.
The struggle is worsened if users have not established sustainable dietary or behavioural changes during treatment.
Significant Adoption
Figures indicate that millions of people in the UK have tried these injections in the past year, with desire being substantial.
- Use is greater among females than men.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
In conclusion, experts stress that while the jabs are potent tools for shedding pounds, they are not a standalone solution and long-term success likely depends on integrated lifestyle management.
